Targeting cancer stem cells with ribosome-inactivating proteins: from molecular mechanisms to clinical translation.

Rai A, Vikram A, Singh TP, Sharma P, Sharma S

Open source

DOI
10.1080/14737140.2026.2738622
Published
2026 Sep 23
Container
Expert review of anticancer therapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14737140.2026.2738622,
  title = {Targeting cancer stem cells with ribosome-inactivating proteins: from molecular mechanisms to clinical translation.},
  author = {Rai A and Vikram A and Singh TP and Sharma P and Sharma S},
  year = {2026},
  journal = {Expert review of anticancer therapy},
  doi = {10.1080/14737140.2026.2738622},
  url = {https://doi.org/10.1080/14737140.2026.2738622}
}

RIS

TY  - JOUR
TI  - Targeting cancer stem cells with ribosome-inactivating proteins: from molecular mechanisms to clinical translation.
AU  - Rai A
AU  - Vikram A
AU  - Singh TP
AU  - Sharma P
AU  - Sharma S
PY  - 2026
JO  - Expert review of anticancer therapy
DO  - 10.1080/14737140.2026.2738622
UR  - https://doi.org/10.1080/14737140.2026.2738622
ER  - 

APA

A, R., A, V., TP, S., P, S., & S, S. (2026). Targeting cancer stem cells with ribosome-inactivating proteins: from molecular mechanisms to clinical translation.. Expert review of anticancer therapy. https://doi.org/10.1080/14737140.2026.2738622

Source records